Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.58 - $4.68 $35,604 - $64,583
13,800 New
13,800 $37,000
Q2 2022

Aug 15, 2022

SELL
$3.11 - $7.48 $311,000 - $748,000
-100,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.88 - $8.56 $183,000 - $321,000
37,500 Added 60.0%
100,000 $82,000
Q4 2021

Feb 14, 2022

BUY
$7.03 - $13.03 $300,884 - $557,684
42,800 Added 217.26%
62,500 $11,000
Q2 2021

Aug 16, 2021

SELL
$13.68 - $22.34 $564,984 - $922,642
-41,300 Reduced 67.7%
19,700 $2,000
Q1 2021

May 17, 2021

SELL
$9.0 - $63.91 $299,700 - $2.13 Million
-33,300 Reduced 35.31%
61,000 $90,000
Q4 2020

Feb 10, 2021

BUY
$4.82 - $10.1 $29,402 - $61,610
6,100 Added 6.92%
94,300 $81,000
Q3 2020

Nov 16, 2020

BUY
$4.7 - $8.7 $414,540 - $767,339
88,200 New
88,200 $15,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $832M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.